Pages

Friday 22 June 2012

Biotherm Skin Vivo Uniformity

Biotherm Skin Vivo Uniformity

In formulating Biotherm Skin Vivo Uniformity, an anti-aging texture and tone reversive day cream, scientists at Biotherm have combined their knowledge of both the clinical signs of aging and genomics (the study of genetics and DNA) to identify and target five key irregularities involved in the loss of skin condition – hyperpigmentation or uneven dark patches, redness, dull tone, roughness and loss of elasticity. Whatever the season, climate or altitude, Ultra Violet or sun exposure remains the primary cause of premature aging of the skin. Skin Vivo Uniformity, the latest in Biotherm’s advanced anti-aging range of face creams, is scientifically proven to help visibly rejuvenate and protect the skin’s appearance by returning a more uniform-looking complexion.

Formulated with five active ingredients combined with UVA/UVB Sun Protection Factor 15, Biotherm Skin Vivo Uniformity contains Saccharomyces Cerevisiae, derived from a micro-organism chosen for its action on dermal proteins. Vitamin CG, a derivative of Vitamin C chosen for its anti-aging, exfoliating and anti-pigmentation properties. ER 195, derivative of salicyclic acid chosen for its micro-exfoliating effect to remove excess dead skin cells that can dull the complexion. Reverserol SV, Senna alata leaf extract chosen for its self-protecting properties. Pure Thermal Plantkon, chosen for its skin-smoothing properties.


This product is recommended for normal and combination skin and with regard to skin tone, I found it delivered a decrease in the appearance of pigmentation imperfection, a decrease in the appearance of redness and an increase in skin luminosity. Skin texture feels refined. There are fewer visible pores. Skin feels more supple. Skin Vivo Uniformity by Biotherm is in fact a supercream. You can feel its potency immediately. Apply once daily and again at night. £59.00 for 50ml. Available at selected Boots or on Amazon or locate a store at  www.biotherm.co.uk


No comments:

Post a Comment

LinkWithin